Schwarz Pharma's foray into the central nervous system
disorder market is beginning to pay serious dividends as the
firm's ground-breaking transdermal patch for Parkinson's continues
to prove a success story, now gaining...
Oxford Biomedica has made available preclinical efficacy data,
which suggests that gene-based product could have significant
efficacy for those suffering from Parkinson's disease when compared
to current treatment methods.
A simple laboratory method to treat Parkinson's disease, which
involves electric currents, has been developed by researchers, who
believe the use of this method will reduce or eliminate the need to
treat this disorder with drug...
Scientists researching pharmaceutical treatments for Parkinson's
disease are invited to submit study information to a new patient
website, which is intended to improve access to information on
Parkinson's clinical trials,...
Research that could eventually lead to gene therapy treatment
options for patients with Parkinson's disease has been published
this week, which could bring hope to more than 1 million Americans
each year who suffer from this...
A research team based in Sweden is benefiting from a medical
charity grant of $3 million (€2.5m) that will help it develop a new
cell-based therapy for Parkinson's. Current therapies can only
ameliorate the symptoms of the disease.